First Horizon Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.75M | Buy |
9,940
+210
| +2% | +$163K | 0.2% | 131 |
|
|
2025
Q1 | $8.04M | Sell |
9,730
-227
| -2% | -$189K | 0.23% | 124 |
|
|
2024
Q4 | $7.69M | Sell |
9,957
-100
| -1% | -$82.8K | 0.22% | 125 |
|
|
2024
Q3 | $8.91M | Buy |
10,057
+26
| +0.3% | +$23.4K | 0.25% | 121 |
|
|
2024
Q2 | $9.08M | Buy |
10,031
+431
| +4% | +$345K | 0.28% | 111 |
|
|
2024
Q1 | $7.47M | Sell |
9,600
-3,063
| -24% | -$2.18M | 0.23% | 124 |
|
|
2023
Q4 | $7.38M | Sell |
12,663
-416
| -3% | -$243K | 0.24% | 121 |
|
|
2023
Q3 | $7.03M | Buy |
13,079
+908
| +7% | +$468K | 0.25% | 118 |
|
|
2023
Q2 | $5.71M | Sell |
12,171
-109
| -0.9% | -$45.7K | 0.2% | 136 |
|
|
2023
Q1 | $4.22M | Buy |
12,280
+6,112
| +99% | +$2.06M | 0.15% | 154 |
|
|
2022
Q4 | $2.26M | Sell |
6,168
-991
| -14% | -$351K | 0.08% | 199 |
|
|
2022
Q3 | $2.31M | Sell |
7,159
-501
| -7% | -$159K | 0.09% | 196 |
|
|
2022
Q2 | $2.48M | Buy |
7,660
+2,583
| +51% | +$775K | 0.09% | 196 |
|
|
2022
Q1 | $1.45M | Sell |
5,077
-338
| -6% | -$87K | 0.08% | 205 |
|
|
2021
Q4 | $1.49M | Sell |
5,415
-311
| -5% | -$78.8K | 0.05% | 247 |
|
|
2021
Q3 | $1.32M | Buy |
5,726
+2,521
| +79% | +$622K | 0.04% | 253 |
|
|
2021
Q2 | $735K | Buy |
3,205
+29
| +0.9% | +$5.83K | 0.04% | 219 |
|
|
2021
Q1 | $592K | Sell |
3,176
-90
| -3% | -$17.6K | 0.03% | 238 |
|
|
2020
Q4 | $550K | Sell |
3,266
-30
| -0.9% | -$4.48K | 0.04% | 216 |
|
|
2020
Q3 | $487K | Buy |
3,296
+316
| +11% | +$48.9K | 0.04% | 207 |
|
|
2020
Q2 | $488K | Hold |
2,980
| – | – | 0.04% | 207 |
|
|
2020
Q1 | $413K | Sell |
2,980
-234
| -7% | -$32.2K | 0.04% | 212 |
|
|
2019
Q4 | $421K | Sell |
3,214
-61
| -2% | -$7.07K | 0.03% | 238 |
|
|
2019
Q3 | $366K | Buy |
3,275
+95
| +3% | +$10.6K | 0.03% | 248 |
|
|
2019
Q2 | $352K | Buy |
3,180
+132
| +4% | +$15.5K | 0.03% | 259 |
|
|
2019
Q1 | $395K | Buy |
3,048
+234
| +8% | +$28.5K | 0.03% | 243 |
|
|
2018
Q4 | $326K | Sell |
2,814
-600
| -18% | -$67K | 0.03% | 263 |
|
|
2018
Q3 | $366K | Hold |
3,414
| – | – | 0.03% | 283 |
|
|
2018
Q2 | $292K | Sell |
3,414
-2,360
| -41% | -$194K | 0.02% | 312 |
|
|
2018
Q1 | $447K | Buy |
5,774
+86
| +2% | +$6.92K | 0.04% | 214 |
|
|
2017
Q4 | $481K | Buy |
5,688
+2,824
| +99% | +$240K | 0.05% | 213 |
|
|
2017
Q3 | $246K | Hold |
2,864
| – | – | 0.03% | 286 |
|
|
2017
Q2 | $235K | Sell |
2,864
-3,301
| -54% | -$269K | 0.03% | 285 |
|
|
2017
Q1 | $516K | Buy |
6,165
+895
| +17% | +$71.7K | 0.06% | 208 |
|
|
2016
Q4 | $421K | Hold |
5,270
| – | – | 0.05% | 223 |
|
|
2016
Q3 | $421K | Sell |
5,270
-16,027
| -75% | -$1.28M | 0.05% | 220 |
|
|
2016
Q2 | $1.68M | Buy |
21,297
+1,642
| +8% | +$124K | 0.23% | 112 |
|
|
2016
Q1 | $1.43M | Sell |
19,655
-1,648
| -8% | -$125K | 0.16% | 130 |
|
|
2015
Q4 | $1.79M | Buy |
21,303
+2,896
| +16% | +$240K | 0.32% | 95 |
|
|
2015
Q3 | $1.54M | Sell |
18,407
-479
| -3% | -$40.4K | 0.24% | 114 |
|
|
2015
Q2 | $1.58M | Buy |
18,886
+1,478
| +8% | +$113K | 0.23% | 121 |
|
|
2015
Q1 | $1.27M | Buy |
17,408
+2,154
| +14% | +$153K | 0.18% | 136 |
|
|
2014
Q4 | $1.05M | Buy |
15,254
+20
| +0.1% | +$1.35K | 0.16% | 143 |
|
|
2014
Q3 | $986K | Buy |
15,234
+815
| +6% | +$51.6K | 0.15% | 150 |
|
|
2014
Q2 | $892K | Buy |
14,419
+3,718
| +35% | +$222K | 0.13% | 169 |
|
|
2014
Q1 | $633K | Buy |
10,701
+1,407
| +15% | +$78.5K | 0.09% | 187 |
|
|
2013
Q4 | $411K | Buy |
9,294
+1,354
| +17% | +$67.8K | 0.06% | 218 |
|
|
2013
Q3 | $400K | Buy |
7,940
+7,720
| +3,509% | +$404K | 0.06% | 206 |
|
|
2013
Q2 | $11K | Buy |
+220
| New | +$12K | 0.01% | 502 |
|
Other funds holding LLY
First Horizon Advisors's LLY Position: Q2 2025 in Review
First Horizon Advisors increased its Eli Lilly (LLY) stake by 2.2% in Q2 2025, buying an estimated $163K and bringing the position to 9,940 shares worth $7.75M. The position accounts for 0.2% of the portfolio, ranked #131.
First Horizon Advisors first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $9.08M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.
- First Horizon Advisors held 9,940 shares of Eli Lilly worth $7.75M as of Q2 2025.
- First Horizon Advisors bought 210 Eli Lilly shares in Q2 2025, an estimated $163K.
- Eli Lilly made up 0.2% of First Horizon Advisors's portfolio in Q2 2025, its #131 holding.
- First Horizon Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Eli Lilly position peaked at $9.08M in Q2 2024.
- 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.